• Exchange: Continuous
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GRF:SM

36.7800 EUR 0.3750 1.03%

As of 11:38:00 ET on 04/17/2014.

Snapshot for Grifols SA (GRF)

Open: 36.5100 Day's Range: 36.1150 - 36.9050 Volume: 1,568,928
Previous Close: 36.4050 52wk Range: 25.0550 - 42.0950 1-Yr Rtn: +29.78%

Stock Chart for GRF

No chart data available.
  • GRF:SM 36.7800
  • 1D
  • 1M
  • 1Y
36.4050
Interactive GRF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GRF

Current P/E Ratio (ttm) 36.6704
Estimated P/E(12/2014) 22.3587
Relative P/E vs. IBEX 1.9564
Earnings Per Share (EUR) (ttm) 1.0030
Est. EPS (EUR) (12/2014) 1.6450
Est. PEG Ratio 1.1514
Market Cap (M EUR) 11,483.41
Shares Outstanding (M) 213.06
30 Day Average Volume 965,044
Price/Book (mrq) 5.9601
Price/Sale (ttm) 4.5680
Dividend Indicated Gross Yield 0.54%
Cash Dividend (EUR) 0.1580
Dividend Ex-Date 06/05/2013
5 Year Dividend Growth 4.01%
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GRF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GRF

Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, Enteral nutrition, diagnostic systems, and medical materials.

Victor Grifols RouraChairman/CEOAlfredo Arroyo GuerraVP:Administration & Finance
Ramon Riera RocaVP:Marketing & SalesAlbert Grifols RouraGen Dir:Grifols Laboratories
More Company Profile & Key Executives for GRF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil